Gosset Ownership
Private
Employees
~50
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Altacor General Information
Altacor has a portfolio of commercialized products in the UK and Ireland for dry eye and surgical use. Its Clinitas line addresses moderate dry eye with high hyaluronic acid content. BioLon® viscoelastic device supports cataract surgery. The company continues to develop new products targeting unmet needs in ophthalmology, including orphan indications and glaucoma. It has demonstrated strong performance in the UK market and aims for European/global expansion. No recent clinical trial results are publicly detailed.
Contact Information
Primary Industry
Surgical Medical Devices
Corporate Office
Windsor* / Reading*, Berkshire/Buckinghamshire area*
United Kingdom
United Kingdom
Drug Pipeline
Clinitas
CommercialKey Partnerships
Actively seeking partnerships for distribution/international expansion; no major pharma partners named yet.
Altacor Funding
No funding data available
To view Altacor's complete valuation and funding history, request access »